donic acid metabolism, including rabbit aorta contracting substance (Palmer et aI. , 1973) , the cy clic endoperoxides, PGG2 and PGH2 (half-life of 5 min) and thromboxane A2 , which has a half-life of 30 s, and its inactive metabolite thromboxane B2 (Samuels son et aI. , 1978, for review) . Many tissues, particularly platelets, have the capacity to generate thromboxane A2 , which is very potent both at in ducing platelet aggregation and in contracting smooth muscle.
In 1976 came the description of the physiological antagonist to thromboxane A2. Vane's group demon strated that microsomes fr om arterial walls enzy matically transform PGG2 and PGH2 to an unstable product (half-life of 2 -3 min in blood) that relaxes arterial strips and prevents platelet aggregation prostacyclin or PGI2 (Moncada and Vane , 1978, for review) . Prostacyclin synthetase is abdundant in the intima and decreases in concentration progres sively from the intima to the adventitia. A lipid peroxide , 15-hydroperoxyarachidonic acid, strong ly inhibits prostacyclin synthetase.
Finally, the alternative lipoxygenase pathway for arachidonate metabolism has been explored re cently and the whole family of so-called leuko trienes identified (Samuelsson and Hammarstrom, 1980; Piper, 198 1) . The rate-limiting step for any of these pathways appears to be the provision of the substrate-arachidonic acid-by the phospholipase reaction (Flower and Blackwell, 1976) . The intra cellular concentration of arachidonic acid is nor mally very low-prostaglandin synthetase is a microsomal enzyme. Phospholipase A2 is inhibited both by drugs such as mepacrine and by anti inflammatory steroids like dexamethasone (Flower and Blackwell, 1979, for review) . The regulation of arachidonic acid production by the phospholipid methylation reactions and by the phosphatidyl inositol cycle is a rapidly evolving subject (Hirata and Axelrod, 1980; Lapetina, et aI ., 1981) .
The stimulus for suggesting that arachidonic acid derivatives are involved in the control of the cere bral circulation comes from an association of con cepts . The cellular membranes of the brain are rich in polyunsaturated fatty acids, particularly arachi donic acid, bound in the membrane as phos pholipids. A characteristic property of such unsatu rated fatty acids is that in the oxygen-rich, metal containing medium in which they are bathed, they are susceptible to peroxidative attack (Slater, 1972) . Such products of arachidonic acid metabolism (Fig.  1) , like the prostaglandins, are generated by the brain, but their role is poorly defined (Wolfe and Coceani, 1979) . Their chemical structure suggests that they play a role in membrane phenomena. In some segments of the gut and circulation, intrinsic tone has been related to the endogenous production of prostaglandins (Eckenfels and Vane , 1972) . In adipose tissue, the coupling between corticotropin stimulated lipolysis and reactive hyperaemia is blocked by inhibition of endogenous prostaglandin production (Bowery and Lewis , 1973) . A vast number of pharmacological effects have been as cribed to the prostaglandins. It is dangerous to generalise between tissues and between species. Some arachidonate derivatives are peripheral va sodilators , some vasoconstrictors (Bergstrom et aI ., 1968) . Some fu nction as fe edback modulators of noradrenaline release at sympathetic nerve termi nals (Hedqvist, 1970) .
Arachidonate metabolites are released with tissue trauma, and there is abundant evidence for their participation in the inflammatory process, oedema fo rmation (involving both cyclo-oxygenase and lipoxygenase pathways) , platelet aggregation (in volving generation of thromboxane A2 by the platelets) , and the ability of the vascular en dothelium to resist platelet deposition (by producing the anti-aggregatory and vasodilator prostacyclin Vane , 1978 , 1979 ; Williams, 1979) .
Cerebral Arachidonic Acid Metabolism Figure 1 summarizes the various, currently de scribed pathways of metabolism of arachidonic acid. Different tissues in different species vary in their utilization of these pathways. PGE2 and PGF2a are released in nanogram amounts into superfu sates of the cerebral cortex, cerebellum, and spinal cord (Horton, 1969 ; Coceani, 1974, for review) . The prostaglandins released do not come fr om pre formed stores but are fo rmed during the stimulation PGF2 a 1 period: larger amounts are released than can be ex tracted from the tissue (Piper and Vane , 1971 ). Levels of prostaglandins may be extremely low or undetectable if synthetic reactions are blocked be fore dissection. With hindsight, it is clear that the wide variation in reported values of prostaglandin concentration in the brain reflects post-mortem synthesis (Samuelsson, 1964; Horton, 1969 ; Co ceani, 1974) . By comparing rats killed by focussed microwave irradiation and by decapitation with subsequent ischaemia, Bosisio et aI. , 1976 , demon strated that the release of fr ee arachidonic acid oc curs mainly during the time interval between the sac rifice of the animals and the beginning of tissue in cubation, whereas prostaglandins are formed during the incubation assay. The level of free arachidonic acid in normal brain tissue is very low. With de capitation and subsequent ischaemia, activation of phospholipase A2 occurs with greatly enhanced re lease of free arachidonic acid from tissue phos pholipids. Free arachidonic acid can increase by 40 J.Lglg of tissue after 3 min of brain ischaemia. Eleva tion of free arachidonic acid levels also occurs with cerebral trauma, seizures, and electroshock (Bazan , 1970 (Bazan , , 1971 . Phospholipase A2 may be the rate limiting step in the formation of prostaglandins by controlling the supply of the precurser, arachidonic ac id (Flower and Blackwell, 1976) . Unfortunately, the study of cerebral prostaglandin synthesis has been complicated by the fact that conversion of ex ogenous arachidonic acid by brain is less than 2% whether a homogenate or microsomal fraction is used (Coceani, 1974; Pace-Asciak and Nashat, 1976) . Hence cerebral prostaglandin synthesis is often assessed by in vitro incubation assays. The choice of incubation medium and cofactors may determine the pattern of metabolites fo und. Whole brain tissue will generate PGF2" and PGE2 (man ; Abdel-Halim et aI. , 1980), PGD2, throm boxane B2, and PGF2" (rat, guinea-pig) , PGF2" (rabbit) , and PGE2 (cat) (Wolfe, 1978; . These reports are not always consistent. Human brain tissue produces little prostacyclin as reflected in the low levels of its sta ble metabolite 6-keto-PGFta. Cell-free cerebro spinal fluid (CSF) has the advantage that any prostaglandins it contains will not be an ischaemic artefact. Unfortunately, the lumbar CSF level bears little relation to even the bulk cisternal level be cause of rapid transport of prostaglandins from the brain into the blood stream (Hagen et aI. , 1977) . CSF from normal patients contains 6-keto-PGFt" , less than 100 pglml of PGF2" , even less PGE2, and no detectable PGD2 (La Torre et aI. , 1974 ; Wolfe and Marner, 1975 ; Hagen et aI. , 1977 ; Abdel-Halim, et aI. , 1979) .
Why is there so much prostacyclin metabolite (6-keto-PGF\a) and so little PGF2" and PGE2 in human CSF when whole brain tissue generates PGF2" and PGEz and not PGI2/6-keto-PGF\,,? In part this is explained by the removal of PGF2" fr om the extracellular fluids of the brain by a saturable , fac ilitated transport process across both the choroi dal and extrachoroidal regions of the blood-brain barrier systems (Bito et aI. , 1976) . Stable prosta glandins such as PGF2a penetrate poorly through the normal cell membrane but are accumulate d against the concentration gradient by the choroid plexus. Such fac ilitated prostaglandin transport ap pears to be the main mechanism for the termination of the action of the stable cerebral prostaglandins. The level of prostaglandin-metabolizing enzymes such as the prostaglandin dehydrogenases are very low in homogenates of whole cerebrum or cerebel lum, although the level of prostaglandin reductase may be higher (Nakano et aI. , 1972; Coceani, 1974) . However, it is of considerable intere st that pial and choroid plexus blood vessels may possess high con centrations of prostaglandin dehydrogenase that are not detectable in whole brain samples (Siggins , 1972) . But why does CSF contain 6-keto-PGF\" when whole brain cannot be shown to generate it (Wolfe, 1978 ; Abdel-Halim et aI. , 1980) ?
Cerebrovascular Synthesis of Prostacyclin
The demonstration in 1975 of the production of a prostaglandin-like substance by the bovine middle cerebral artery using bioassay (Pickard et aI. , 1975a ) was the first to show that cerebral prostaglandin synthesis cannot be considered as one homogene ous system-cerebral arteries alone could synthe size large quantities of prostaglandins (2.2 x 10-7 gig wet weight/h). This study was stimulated by the suggestion that intramural generation of prosta glandins maintained the tone of some smooth mus cle preparation (Eckenfe ls and Vane , 1972) . In domethacin inhibited such intramural prostaglandin production and reduced the spontaneous tone of the human umbilical artery (Tuvemo and Wide , 1973) . In contrast, the constriction of the isolated ductus arteriosus and coronary artery produced by in domethacin suggested that in some tissue , there was intramural synthesis of a vasodilator prostaglandin (Coceani et aI ., 1975 ; Kalsner, 1975) . More sophis ticated biochemical techniques revealed that bovine cerebral arteries produced a mixture of 6-keto PGF 1 a , PGF2a , PGE2, PGD2, and thromboxane B2 (Hagen et aI., 1979) . Prostacyclin synthetase activ ity is present in both human and baboon cerebral arteries (Boullin et aI ., 1979; Abdel-Halim et aI ., 1980) . The levels of 6-keto-PGF 1 a found in human cerebral arteries were so high that the much lower levels found in the grey and white matter might re flect its fo rmation in brain capillaries and arterioles alone (Abdel-Halim et aI., 1980) . This was shown in the rat (Goehlert et aI., 1981) . Prostacyclin synthe sis was very active in the choroid plexus (Abdel Halim et aI ., 1980; Goehlert et aI ., 198 1) .
Hence the apparent paradox of high levels of the prostacyclin metabolite , 6-keto-PGF 1 a , in the CSF with low whole brain synthetic capacity is resolved. If such prostacyclin synthesis is confined mainly to the cerebral endothelium as occurs extracranially Vane , 1978, 1979) , has it a role in the modulation of cerebrovascular reactivity or does it act solely in its capacity to repel intracerebral platelet aggregation?
Effect of Prostaglandin Synthesis Inhibitors on the Reactivity of the Cerebral

Circulation-Indomethacin
In the baboon anaesthetized with phencyclidine , nitrous oxide, and oxygen, indomethacin (either 10 mg/kg , i.v., or 0.04-0.2 mg/kg/min by intracarotid infusion) reduces cerebral blood flow (CBF) at normocapnia by some 38% and severely impairs the response to hypercapnia ( Fig . 2) (Pickard and MacKenzie, 1973) . Indomethacin has no effect at hypocapnia. There is no significant change in either cerebral oxygen consumption (CMR02), mean arte rial blood pressure , or mean cerebral perfusion pressure and no constriction of the major inflow tract arteries such as the internal carotid or middle or anterior cerebral arteries. The effect of in domethacin on CBF is very rapid: sagittal pressure starts to decrease within 1 min in man and baboon, and cerebral venous outflow decreases within 15 s in the rat (Sicuteri et aI., 1965 ; Pickard and Mac Kenzie , 1973 ; Dahlgren et aI ., 1981; Pickard , 198 1) . The speed of this response indicates that in domethacin exerts its effect on a compartment in rapid equilibrium with blood, that is, the vessel wall (Dahlgren et aI ., 1981) . It also indicates an ex tremely rapid turnover of the relevant arachidonate J Cereb Blood Flow Melabol. Vol. 1, No. 4, 1981 metabolite, There is a close correspondence be tween the dose-re sponse curve for reduction in CBF and for inhibition of prostaglandin synthesis in the rat (Fig. 3 ). Following cessation of an intra carotid infusion of 60 min of indomethacin, the ef fects on CBF resolve after some 2 h in the baboon. In vitro, when indomethacin is removed from the tissue by washing, its effect is reversed within minutes-it is quite erroneous to assume that indo methacin produces irreversible inhibition of prosta glandin synthesis (Manku and Horrobin, 1976; Hornstra et aI ., 1979) . Furthermore , the pharma codynamics of indomethacin vary considerably between species (Hucker et aI ., 1966) .
Many other workers have now confirmed these cerebrovascular properties of indomethacin in other species, including man (Table 1) . Methodological factors may explain the few discrepancies in the literature . Dawson and Dalessio (1968) employed an inhalation 1 33xenon technique for the measurement of human CBF but made no correction for either arterial re-circulation of 1 33xenon or for the slow extracerebral component of the washout curves. The depression of cerebrovascular reactivity by barbiturate anaesthesia (Fujishima et aI ., 1971; Grubb et aI ., 1974 ; Dahlgren and Siesjo, 1981) , to gether with the semiquantitative heat-clearance method employed, might explain the failure of Cuypers et aI . (1978) to observe any cerebrovascu lar effects with indomethacin. Only a rigorous tech nique for the estimation of cerebral tissue perfusion will suffice to reveal fu rther depression with in domethacin (Dahlgren and Siesjo , 1981) . Further more , Cuypers et aI . dissolved their indomethacin in alcohol and saline, so that the equivalent of 0.4-1.8 ml of 96% ethanol was injected with the indomethacin. During a discussion period at the re cent Tenth International Symposium on Cerebral Blood Flow and Metabolism in St. Louis, Busija and Heistad reported that they could find no effect of indomethacin (up to 10 mg/kg) on the CBF CO2 response in chloralose-anaesthetized cats using the microsphere technique. Again, the considerable de pression of cerebrovascular reactivity to CO2 by chloralose may obscure further changes in such re activity (Sandor et aI ., 1977) . Ruszczewski and Herbaczynka-Cedro (1978) concluded that indomethacin has no effect on the CBF CO2 response, but close scrutiny of their re sults suggests the opposite. They used a combina tion of hexobarbitone, urethane, and chloralose to anaesthetize their dogs. CBF was estimated with - Pickard et aI., 198 1; Dahlgren et aI., 1981 Bill, 1979 Cuypers et aI., 1978 Crockard et aI., 1981 Rabbit Gerbil Dog Cat Ruszczewski & Herbaczynska-Cedro, 1978 Vlahov, 1976 Gabrielyan et aI., 1979 Pial arteries/cerebral arteries
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Brandt, /98 1 CO2 reactivity are a reflection of the anaesthetic regimen. They were unable to detect the efflux of the stable prostaglandins into sagittal sinus blood, using bioassay, with either hypoxia or hypercapnia. Crockard et al. (1981) have shown that I-n-butyl imidazole, a potent inhibitor of thromboxane syn thetase, mimics the effect of indomethacin on the cerebral circulation of the gerbil. It is important to know what effects this compound has on other pathways of arachidonate metabolism in the brain in vivo (Harris et aI. , 1980; Moncada and Vane , 1980) . Where the use of anaesthesia has been avoided and accurate methods of assessing cerebral tissue perfusion are employed, there has been no dis agreement as to the effects of indomethacin on ce rebral blood flow (man , rat , and rabbit). In the con scious rat , indomethacin slightly reduces the animal's mobility but has no other obvious be havioural effects (Dahlgren, 1981; McCulloch et aI. , 198 1) . The application of the [ 1 4C]iodoantipyrine technique in the rat has revealed that indomethacin administration results in reduction in cerebral tissue perfusion in every region of the brain examined by between 30 and 50% fr om vehicle-injected control levels. Furthermore , the administration of indo methacin (0.3 -30 mg/kg , i. v.) does not alter signifi cantly the rate of glucose utilization (using Sokoloffs [ 1 4C]deoxyglucose technique) in any of the 38 discrete regions of the central nervous sys tem that were examined (Grome et aI. , 1980 ;  J Cereb Blood Flow Metabol. Vol. 1, No. 4, 1981
Relaxation
V1ahov & Betz, 1974; Wei et aI., 1980 Pickard et aI., 1976 Chapleau et aI., 1980 Pickard et aI. , 198 1). Furthermore , Siesjo' s group has been unable to find any change in cerebral re dox state with indomethacin despite the large re duction in CBF (Dahlgren, 1981) .
In summary, in studies where rigorous techniques for the estimation of CBF and energy metabolism have been used, indomethacin administration re duces flow and the CBF CO2 response with no sig nificant change in cerebral energy metabolism. Moderate hypercapnia, in both the anaesthetized rat and baboon provokes a small (10-15%) increase in cerebral oxygen consumption of borderline sig nificance (Pickard and MacKenzie , 1973 ; Pickard et aI. , 198Od; Dahlgren et aI. , 198 1) . This small rise is reversed by indomethacin in the baboon but not in the rat. There is no effect of indomethacin on cere bral glucose utilization in the conscious rat. Direct examination of the effects of indomethacin on cere bral arteries in vitro and pial arterioles in situ has shown that indomethacin has little effect on re sting calibre except at high concentrations, when dilata tion of the vessels is observed (Table 1) . There may be a species difference: Brandt (1981) has found that some human cerebral arteries slowly contract with indomethacin (10-6 M). As has been observed pre viously with angiotensin, noradrenaline , and sero tonin, for example , the responses of pial arteries do not always provide a reliable guide as to the effects of the agent on cerebral tissue perfusion (Edvinsson and MacKenzie, 1977; Pickard, 1978, 1980) . This inability to use an isolated cerebral ar tery as a reproducible model of the cerebrovascular effects of indomethacin is a considerable handicap to exploring the detailed cellular mechanisms in volved (vide infra). There are no published obser vations on the chronic effects of indomethacin on CBF. The neonatal lung adapts to chronic inhibition of prostaglandin synthesis, maintaining normal vas cular tone and homeostasis (Lock et aI. , 1980) .
Relationship Between Local Energy
Metabolism and Local Blood Flow in the Brain
It is a cherished concept dating fr om Roy and Sherrington (1890) that the regulation of the cere bral circulation is at least in part mediated by the products of cerebral metabolism and that CBF is adjusted to local cerebral metabolic and fu nctional activity. The availability of the [ 1 4C]deoxyglucose method for measuring glucose utilization and the . .
Relationship between CBF and cerebral glucose utilization in conscious rats that received vehicle (e) and in animals that received indomethacin (0). Y = ax + b, where y is CBF and x is cerebral glucose utilization. For injected animals, a = 1.54, r = 0. 95, P < 0.001; and following in domethacin, a = 1.02, r = 0.96, P < 0.001. (From Pickard,
McCulloch, Kelly, and Grome, unpublished observations . )
[ 1 4C] iodoantipyrine method for measuring blood flow in individual discrete structural and fu nctional components of the brain has made it possible to examine directly the relationship between them (Sokoloff, 1981) . In the conscious rat, there is a highly significant correlation between the rate of glucose utilization and blood flow in different cere bral structures (Fig. 4) . The relationship between blood flow and glucose utilization is fu ndamentally altered following indomethacin (Pickard et aI. , 198 1) . However, there is still coupling between the two parameters , and the hierarchy of blood flow levels present in normal animals (that is, greatest in primary auditory areas, lowest in regions of white matter) is maintained fo llowing indomethacin. Whether this is indicative of the incompleteness of inhibition of prostaglandin synthesis or of the in volvement of other mechanisms in the coupling of fl ow and glucose use remains to be elucidated. These results provide no positive evidence for a role for cyclo-oxygenase products in neuronal acti vity as reflected in local cerebral glucose utiliza tion, but their effects may be more subtle.
Neurones may possess a prostaglandin-and prosta cyclin-sensitive adenylate cyclase (Blair et aI. , 1980) .
Indomethacin and Autoregulation, Reactive
Hyperaemia, and the Cerebrovascular Response to Functional Activation,
Bicuculline-Induced Seizures, Hypoglycaemia and Hypoxia
The impairment of the CBF CO2 response by in domethacin is singularly specific. Indomethacin has much less effect on any other aspect of cerebro vascular reactivity yet examined except, possibly, on reactive hyperaemia. However, not all these re sponses have yet been adequately explored.
Indomethacin has no effect on the autoregulatory curve, including its lower limit to haemorrhagic hypotension and its upper limit to angiotensin induced hypertension, in either the anaesthetized baboon or gerbil (Pickard et aI. , 1977b ; Crockard et aI. , 198 1) . An intracarotid infusion of indomethacin was used in the baboon to ensure that a falling plasma level of indomethacin did not complicate interpretation of the protracted experiments re quired to study autoregulation. The only change in the autoregulatory curve was that indomethacin significantly reduced the ab solute value of CBF at all levels of mean arterial pressure but not the over-all pattern of response. The effects of indomethacin on the transient cerebrovascular responses to changes in cerebral perfusion pressure , as opposed to steady-state changes, have not yet been exam ined. In the kidney, it was suggested originally that autoregulation was impaired by indomethacin. The consensus view now is that steady-state autoregu lation is unaffected but that transient responses may be impaired by indomethacin (Herbaczynska-Cedro and Venuto et aI. , 1975; Beilin and Bhattacharya, 1977) .
Other conditions such as carotid ligation and mechanically or serotonin-induced carotid artery spasm that impair the CBF CO2 response also abolish or radically alter the cerebrovascular re sponses to hypoxia and changing perfusion pressure (Jennett et aI. , 1976) . There is no angiographic evi dence to suggest that indomethacin provokes any occlusion or spasm of either the internal carotid ar tery or the major intracranial arteries. Furthermore , indomethacin has no effect on the CBF response to hypoxia (Sakabe and Siesjo, 1979) .
These results have implications for theories of cerebral autoregulation. Apart from possible neu rogenic influences, there are two main hypoth eses to account for autoregulation within the cere bral circulation: the myogenic and the metabolic (Bayliss, 1902; Johnson, 1964) . In view of the find ings with indomethacin, the metabolite is unlikely to be carbon dioxide. It is also unlikely to be either H+ or K+-the pial arteriolar calibre changes in re sponse to hypo-and hypertension are not accom panied by alteration in perivascular H+ or K+ con centrations (Wahl and Kuchinsky , 1979) .
Inhibition of prostaglandin synthesis by in domethacin impairs the reactive hyperaemia fol lowing temporary arterial occlusion in the kid ney, heart, and some skeletal muscle (e.g. , Her baczynska-Cedro and Kilborn and Wennmalm, 1976) . In the gerbil, reperfusion of the brain, after episodes of brief ischaemia, re sults in a large accumulation of arachidonic acid metabolites in brain tissue , including PGF2co PGE2, throm boxane B2, and 6-keto-PGF 1 o< (Gaudet and Levine , 1979) . As in vascular smooth muscle, enough oxy gen has to be present for conversion of the arachi donic acid, released from phospholipids during is chaemia, by cyclo-oxygenase (Kalsner, 1977) . Re establishment of blood flow restores tissue oxygen sufficiently. Vlahov (1976) found that indomethacin (10 mg/kg , i.v.) impaired the reactive hyperaemia provoked by
the clamping of both carotid arteries in the cat for 1 min. Barbiturate anaesthesia and a heat-clearance technique were used.
Functional activation of the brain may be consid ered as either "physiological" or "pathologicaL" Electrical stimulation of the nose of the rat presum ably involves activation of both somatosensory and pain pathways. Nilsson et ai. (1981b) found that CBF, as estimated by the [14C]iodoantipyrine auto radiographic technique , increased to 150% or more in frontal, sensorimotor, and parietal cortex and thalamus, and to about 100-130% in other structures. Indomethacin reduced base-line CBF to about 50%. From this level the percentage increase induced by electrical nasal stimulation was of the same magnitude as in untreated animals, but the pattern of specific somatosensory activation was abolished.
The effect of indomethacin on the cerebrovascu lar response to bicuculline-induced seizures is as complex as the response itself. As a generalisation, in the selectively vulnerable areas where changes in local cerebral glucose utilization eventually greatly exceed the increase in local CBF, indomethacin has no effect. Where the coupling between local cere bral glucose utilization and local CBF remains in tact, as in the cerebellum, indomethacin abolishes the increase in CBF (Ingvar et aI. , 1981; Ingvar and Siesjo , 1981) .
Indomethacin has no effect in the rat on the global cerebrovascular re sponse to either insulin-induced hypoglycaemia or hypoxia (Sakabe and Siesjo , 1979; Nilsson et aI. , 1981a) .
The effect of indomethacin in the conscious rat on the coupling between local CBF and local cerebral glucose utilization, in regions of different "resting" activity , suggests that part of the physiological couple is inhibited by indomethacin. As indometha cin only inhibits cerebral prostaglandin synthesis by 80%, the residual 20% may be disproportionately important in the coupling mechanism. Alterna tively , other coupling mechanisms such as K+, Ca 2 +, extracellular fluid pH, and adenosine may be important. With pathological cerebral activation, indomethacin has little or no effect on CBF.
Pharmacology of Indomethacin
The half-life of indomethacin in aqueous solution at room temperature is 200 h at pH 8.0 and 90 min at pH 10.0 (Merck, Sharp & Dohme data). Its solution is yellow to yellowish-green. Prolonged exposure to a high pH results in loss of the yellow colour and degradation to p-chlorobenzoic acid and 2-methyl-5-methoxy-indole-3-acetic acid. In massive doses this indole has platelet anti-aggregatory properties (Rosenblum et aI. , 198 1) . Clearly, any solvent must have no cerebrovascular or systemic effects. In domethacin (Merck Sharp & Dohme or Sigma) will dissolve in a sodium bicarbonate/saline solution (NaHC03, 0. 13 g/ 100 ml; NaCl, 0.8 1 g/ 100 ml at pH 8-8.5) or, more rapidly, in a sodium carbonate so lution. Once dissolved, the pH is corrected to pH 7.4 or arterial blood pH sufficiently gently to avoid precipitation of the indomethacin.
The pharmacodynamics of indomethacin vary among species, and the blood-brain barrier com pounds the problem still fu rther (Hucker et aI. , 1966) . As pointed out earlier, indomethacin does not provide irreversible inhibition of the cyclo oxygenase enzyme. In order to avoid a falling plasma level during protracted experiments , an intracarotid infusion regimen, using a physiological buffer for indomethacin has been devised (Pickard and MacKenzie , 1973) . Unfortunately, this has been misunderstood by some workers. It is not a realistic re-examination of this technique to infuse 1 mllmin of the buffer, without apparent pH or tem perature correction, into the vertebral artery of a cat for 2 h before examining its effect on pial ar teriolar diameter. The effect on cerebral tissue per fu sion of either an intravenous bolus injection (10 mg/kg) in man , rat , and baboon or an intracarotid infusion of indomethacin (0.04-0.2 mg/kg/min) in the baboon is obvious within 1 min and maximal within 10-15 min. In both the baboon and rat , it has been repeatedly demonstrated that the solvent has no effect on local or global CBF, cerebral oxygen consumption, local cerebral glucose utilization, arterial blood gases, arterial blood pressure , or body temperature-this is hardly surprising when its composition is considered (Pickard and Mac Kenzie , 1973 ; Pickard et aI. , 1977b , 198Od ; Sakabe and Siesjo, 1979; Dahlgren, 1981; Pickard et aI. , 1981; Pickard , 1981) .
The original dose of indomethacin used was cal culated on the basis that a tissue level of at least 1 lLg/ml was necessary for inhibition of prostaglandin synthesis and that the brain tissue/plasma ratio for indomethacin was 0.02 (Vane , 1971; Flower and Vane , 1974 ; Hucker et aI. , 1966) . There is now con siderable evidence that indomethacin (1-10 mg/kg) inhibits prostaglandin synthesis in the brain and spinal cord as examined in the rat (PGF: Zatz and Roth, 1975 ; PGF2a and PGE2: Abdel-Halim et aI. , 1978) , cat (PGF: Jonsson and Daniell, 1976) , and gerbil (PGF2a, PGE2, and thromboxane B2: Gaudet and Levine , 1979) . Unfortunately, only Abdel Halim's data refer to the normal animal: properties of the endothelial blood-brain barrier may be im paired after seizures, spinal cord trauma, and tem porary carotid occlusion. These studies need to be extended to provide data on other arachidonate metabolites in other species.
"No drug exerts a single action. The aspirin-like drugs are certainly no exception ; but, at worst, these drugs may be regarded as 'preferential inhib itors' of prostaglandin synthesis, and at best as 'selective inhibitors'" (Flower, 1974) . Fortunately, indomethacin is a relatively "clean drug" -the concentration required to inhibit prostaglandin synthetase in most tissues and species is generally much lower than the concentrations that inhibit other enzymes (Flower, 1974, for review) . None of the other reported actions of indomethacin appears to explain the effect of indomethacin on the cerebral circulation. Indomethacin can influence a variety of prostaglandin-metabolising enzymes, although they are of little importance in the brain (Flower, 1974 ; Pace-Asciak and Cole , 1975) . However, the prosta glandin dehydrogenases, whose inhibition would di rectly affect levels of the active prostaglandins, are not affected except at much higher doses of in domethacin than enzymes that act later in the degradative pathways. Bito and Salvador (1976) fo und that low doses of indomethacin stimulate and high doses inhibit prostaglandin transport by the choroid plexus. It will be interesting to see its ef fe cts on the luminal and anti-luminal membrane transport of various arachidonate derivatives by the cerebrovascular endothelium (Betz et al. , 1980) . However, the overall effect of indomethacin (3-10 mg/kg) is to reduce cerebral prostaglandin levels by up to 80%.
Phosphodiesterase is sensitive in some tissues to indomethacin (Flower, 1974) . Inhibition of this en zyme in the brain would be predicted to produce cerebral vasodilatation both by a direct vascular smooth muscle effect and secondarily via stimula tion of cerebral metabolism. Indomethacin has ef fects on various ionic fluxes in molluscan neurones and various human and guinea-pig tissues but only at concentrations of 0.5-1 mM (Northover, 1973 ; Levitan and Barker, 1972) . The direction of these membrane phenomena, when applied to the in vivo situation, would predict that indomethacin would provoke vasodilatation, not vasoconstriction. In some tissues, phospholipase A2 and cyclic AMP dependent protein kinase are inhibited by micro molar concentrations of indomethacin (Kantor and Hampton, 1978; Kaplan et aI. , 1978) . However, the effect on protein kinase has been disputed, and it probably occurs only at a concentration of in domethacin of 10-4 M and above (Goueli and Ahmed, 1980) . Siegel et al. (1979) have reported that high concentrations of indomethacin will im pair the lipoxygenase pathway.
Other Inhibitors of eyclo-oxygenase
When the various nonsteroidal anti-inflammatory agents are compared, as the ICso for prostaglandin synthetase decreases, so the degree of plasma pro tein binding increases, and solubility in an accept able buffer for in vivo work becomes more difficult, particularly for cerebrovascular studies. For exam ple, meclofenamic acid is up to threefold more ef fe ctive than indomethacin in inhibiting prosta glandin synthesis in various homogenates or sub cellular fractions in vitro, but 99.8% of it binds to plasma protein (Flower and Vane , 1974; Cesarini et aI , 1977) . Transfer across the blood-brain barrier would be minimal. Furthermore , it is only soluble at high alkaline pH.
The only other prostaglandin synthesis inhibitor that has been examined critically for its cerebrovas cular effects is salicylate (Pickard et aI., 1977, 198fu) . The salicylate story is a salutary reminder of the pitfalls that await the unwary. Scrupulous monitor ing of systemic parameters (blood pressure , blood gases, body temperature) and cerebral oxygen me tabolism are essential if changes in CBF are to be evaluated usefully. Salicylate is as effective as aspi rin in vivo in inhibiting extracranial prostaglandin synthesis, but this is not true in vitro (Hamberg , 1972; Willis et aI. , 1972) . However, a metabolite of salicylate fo und in the body, gentisic acid, is a very effective inhibitor of prostaglandin synthetase (Flower, 1974) . With regard to the brain , Cranston et ai. (1975) found that sodium salicylate will abolish the rise in PGE in the CSF provoked by pyrogen fever. Abdel-Halim et al. (1978) could find no effect of aspirin (100 mg/kg by subcutaneous injection) after 30 min; blood-brain barrier transfer of salicy late is very slow (Goldberg et aI. , 1961) . Gaudet and Levine (1979) did find that aspirin (200 mg/kg, i. v.) reduced cerebral prostaglandin synthesis in the gerbil.
J Cereb Blood Flow Metabol. Vol. I, No. 4, 1981 In the anaesthetized baboon, sodium salicylate (50 mg/kg , i.v.-plasma level 1 mmoVL; 200 mg/kg , i. v .-plasma level 2 -3.5 mmoVL) had various sys temic effects including a rise in Paco2 and a rise of body temperature at the higher dose. The most dramatic change was the very large increase (up to 65%) in CMR02 ( Figure 5) . This lagged behind the plasma salicylate level as might be expected from salicylate's tardy passage across the blood-brain barrier. In contrast, there was a very delayed and much smaller rise in cerebral blood flow at nor mocapnia. The cerebrovascular response to hyper capnia was impaired by 47% during the first hour after the administration of 50 mg/kg ; this was the only time and the only dose of sodium salicylate with which CMR02 did not increase. As CMROz increased with salicylate , so the reduction in the CBF CO2 response became insignificant. This suggests that two mechanisms are competing: a di rect effect of CO2 on the arteriolar smooth muscle cell (blocked by indomethacin and partially by salicylate) and a possible enhancement of the CO2 re sponse as a consequence of increasing CMR02 , which is produced by salicylate but not indometha cin. The acute response of CBF to changes in P aC02 depends on the level of CMR02-if CMR02 is de pressed with barbiturate , the hypercapnic CSF re sponse is depressed (Fujishima et al. , 1971; Grubb et al. , 1974) . Unfortunately, there has been no study of the effect of an elevation of CMR02 on the CO2 re sponse with which the salicylate results can be compared.
In man , acute administration of sodium salicylate (1 g, i.v. ; plasma level 0.9-1.6 mmoVL) reduced the CBF CO2 response by 26% with no significant re duction in CBF at normocapnia (Pickard et al. , 1977d) . Chronic administration of aspirin (300 mg orally every 6 h; plasma level 0.6 mmoVL) had no significant effect on CBF and its re sponse to hyper capnia. Amano and Meyer (1981) could not detect any effect of aspirin (only 14.8 mg/kg , orally) on CBF either at normocapnia or hypercapnia.
In summary , in man and baboon, a plasma salicylate level of approximately 1 mmoVL does produce a moderate acute reduction in the CBF CO2 response. At higher plasma levels there is a large increase in cerebral oxygen consumption and body temperature that complicate interpretation of the changes in CBF.
Clearly, it is now necessary to compare the ef ficacies of a range of cyclo-oxygenase , prostacyclin synthetase , and thromboxane synthetase inhibitors on cerebral arachidonate metabolism in vivo with their cerebrovascular effects. Strict monitoring of systemic factors and cerebral metabolism will be required. With the recent introduction of reliable methods for the estimation of local cerebral blood flow , glucose utilization, and oxygen consumption in small animals, this study is now economically feasible.
Cerebrovascular Effects of the Stable
Prostaglandins (PGF2m PGD2, PGE2)
What are the cerebrovascular effects of the rela tively stable prostaglandins (PGF2a, PGD2, and PGE2) that are produced by brain tissue and perhaps by cerebrovascular smooth muscle but not by cerebrovascular endothelium? Will any of them reverse the effects of indomethacin?
The conflicting reports about the effects of the stable prostaglandins on the cerebral circulation ( Table 2 ) may be explained by the failure of some techniques to make a clear distinction between intra-and extracranial vascular beds. Even after external carotid artery ligation, either constant-flow perfusion of the carotid artery or a flow meter probe on the carotid artery will still record extracranial blood fl ow as well as CBF because of the anastomoses through the orbit and to the contra lateral side, particularly in the dog (Purves, 1972; Jennett et al. , 1976) . Angiographic evidence of ab sence of "steal" to extracranial tissues under base-line conditions is no guarantee that vaso dilatation of the temporalis muscle vascular bed will not induce this steal. Finally, to measure CBF alone without some measure of cerebral energy metabolism gives a very inadequate picture.
There is little disagreement that intracarotid ad ministration of PGF2a in fLg/kg doses constricts the large cerebral and pial arteries and reduces CBF ( Table 2) . However, there is a dose-dependent re duction in both CBF (by up to 23%) and cerebral oxygen consumption (by up to 21%) in the anaesthetized baboon. These two effects cannot be separated either by an examination of the dose re sponse curves or by the induction of hypercapnia or hypocapnia. Only the traumatic and unreliable venous outflow technique in the dog has fo und it difficult to reveal this effect of PGF2a (Emerson et aI. , 1974) .
There has been considerable controversy over the cerebrovascular effects of prostaglandins of the E series. The explanation lies in the exquisite sen sitivity of temporalis muscle blood flow to PGE2: it increases by 500% at 1O�7 g/kg/min (Pickard et al. , 1977a) . Only in those investigations where there is the possibility of extracranial contamination has the suggestion been made that PGE! or PGE2 might be vasodilatory (Denton et al. , 1972; Pelofsky et aI. , 1972; Nakano et aI. , 1973) . In addition, alcoholic solutions of the PGE series must be avoided (Yamamoto et aI. , 1972) . Intracarotid infusion of PGE2 has similar but larger effects than PGF2a on CBF and cerebral oxygen consumption. The dose response curves for the two effects are very similar (Pickard et aI. , 1977a) . The intracarotid doses used for these studies are rather high, but these stable prostaglandins penetrate very poorly into the brain (Hansson and Samuels son, 1965; Green et aI. , 1967; Holmes and Horton , 1968) . These high concentra tions of PGE2 constrict the internal carotid artery. To achieve higher brain concentrations of PGE2 but with lower intracarotid doses, the passage of PGE2 across the blood-brain barrier was facilitated by osmotically disrupting the blood-brain barrier (Pic kard et aI. , 1977a,c) . The effects of PGE2 on both CBF and CMR02 were potentiated-there was no evidence of a vasodilatation. Our modification of Rapoport's technique involved the intracarotid in fu sion of 10 ml of a filtered buffe red 2 M urea solu tion over 5-15 s without common carotid clamping. Transient systemic effects subsided within 5 min.
There was no effect on resting CBF, oxygen and glucose metabolism, CO2 reactivity, and auto regulation. This procedure does "open" the cerebrovascular endothelial barrier to substances of a wide range of molecular weights: H2015, penicillin G, fluorescein, noradrenaline, [1 2 5I]albumen, and
Evans blue albumen (Edvinsson and MacKenzie, 1977; Pickard et aI., 1977c; Raichle et aI. , 1977; Chieuh et aI , 1978) . Great care has to be taken in using the urea technique in much smaller species such as the rat without anaesthesia as has been demonstrated by Pappius et aI. (1979) , Gross et aI. (1981) , and Edvinsson et aI. (1978) . Of course, PGF2o: and PGE2 have direct effects on cerebrovascular smooth muscle, but they also de press cerebral oxidative metabolism. Prostaglan dins of the E series will induce profound sedation, stupor, and catatonia (Horton, 1969) . Although PG E2 will reduce the release of noradrenaline at peripheral sympathetic terminals (Hedqvist, 1970) , the evidence that this system operates inside the CNS is much less convincing except with the norad renergic innervation of Purkinje cells (Siggins et aI. , 1971; Bergstrom et aI. 1973; Wolfe and Coceani, 1979; Hillier et aI. , 1980) . However, the release of endogenous cerebral noradrenaline stimulates cere bral oxidative metabolism and CBF (MacKenzie et aI. , 1976) . Alternatively, the changes in CMR02 may reflect the direct metabolic effects on either cerebrovascular endothelial or smooth muscle. The endothelium possesses a very high density of mito chondria (Oldendorf and Brown, 1975) and may be sensitive to prostaglandins via their f3-adrenergic sensitive adenylate cyclase (Nathanson and Glaser, 1979) .
Where an agent has both a direct vasomotor ef fect on the large cerebral arteries and pial arterioles and a cerebral metabolic effect, the evidence suggests that the metabolic effect on CBF predomi-nates. Barbiturate depre ssion of CMR02 also de presses CBF (Fujishima et aI. , 1971; Grubb et aI. , 1974) . Noradrenaline constricts pial vessels but in creases both CBF and CMR02 once its transfer acro ss the blood-brain barrier has been ensured. Serotonin has both vasoconstrictor and vasodilator effects on the inflow-tract vessels but depresses both CMR02 and CBF (Edvinsson and MacKenzie, 1977, for review) . Changing CBF by varying Paco2 has only a minor effect of borderline significance on CMR02 (Fujishima et aI. , 1971; Pickard et aI. , 198W; Dahlgren et aI. , 1981) . Neither PGF2n nor PGE2 af fected any change in CBF in the presence of in domethacin at either normocapnia or hypercapnia in the baboon (Pickard , 1981) .
Cerebrovascular Effects of Prostacyclin
There is an obvious discrepancy between the ef fe cts of prostaglandin synthesis inhibition and the effects of PGE2 and PGF2n on the cerebral circula tion. Similar discrepancies became apparent be tween 1970 and 1976 in other tissues such as the kidney , coronary artery , platelets, and adipose tis sue. The discovery of the short-lived prostacyclin , thromboxane A2 , and cyclic endoperoxides re solved these paradoxes Vane , 1978, 1979) . In the anaesthetized baboon, the intracarotid infusion of prostacyclin not only increases CBF by up to 71%, but also reverses the effect of indometh acin at hypercapnia (Fig. 6) (Pickard et aI. , 198W) . These changes occur despite systemic hypotension and a severe tachycardia. Where arterial blood pressure is returned to near normal with angiotensin during an infusion of prostacyclin and indo methacin, CBF is even further increased. Prosta cyclin and indomethacin are infused via separate systems so that there is no possibility that the Tris buffer (pH 9.0) can degrade the indomethacin. The effects of prostacyclin are not potentiated by tran sient "opening" of the endothelial blood-brain bar rier with the urea technique. This lack of potentia tion has a number of possible explanations. A prec edent for the alternative situation-uptake of PGE2 and PGF2n and not of prostacyclin-is the lung. The selectivity of pulmonary uptake depends on whether any given prostaglandin is a substrate for the carrier mechanism-the subsequent dehydro genase is an intracellular enzyme (Bito et aI. , 1977) . It cannot be that sufficient prostacyclin crosses the endothelium to produce a maximal dilatation of the vascular smooth muscle beyond; 10 -7 g/kg/min does not produce a maximal dilatation. Alterna-tively, metabolism of prostacyclin is so rapid that a transient doubling, say, of transfer is insufficient to produce a maintained and measurable further vaso dilatation. Another possibility may be that the prostacyclin receptor is on the endothelial cell and that there is a second "messenger" system to the vascular smooth muscle. This is a proven possibility for acetylcholine , for which an intact endothelium is required for it to produce relaxation of isolated ce rebral arteries (Furchgott and Zawadzki, 1980; Lee, 1981) . The action of acetylcholine is independent of the cyclo-oxygenase pathway but perhaps not inde pendent of the lipoxygenase pathway (Furchgott and Zawadzki, 1980) . Brain uptake studies with la belled prostacyclin would be very instructive, if technically difficult to perform.
Of course, other vasodilators such as adenosine, A TP, sodium nitroprusside, or halothane might produce cerebral vasodilatation in the presence of indomethacin. But as prostacyclin is naturally pro duced by cerebral blood vessels, it is reasonable to postulate that it might be the proposed intermediate whose synthesis is blocked by indomethacin.
Effects of Arachidonic Acid and Its
Metabolites on Cerebral Arteries and Pial
Arterioles In Vivo and In Vitro
The fa ilure of indomethacin to induce contraction of either isolated cerebral arteries or pial arterioles in situ . except possibly in man , has been a consider able handicap to defining the mechanism of its ac tion (Vlahov and Betz, 1974; Pickard et aI. , 1976; Chapleau et aI. , 1980; Wei et aI. , 198 Ob; Brandt, 1981) . However, the effects of the arachidonic acid metabolites on the extracerebral vessels have been studied extensively and in general confirm that prostacyclin in reasonable concentrations is the only endogenous arachidonate metabolite that is consistently a cerebral vasodilator ( Table 3) . A con sensus emerges when the extensive literature summarized in Table 3 is reviewed; discrepancies remain , however. These may reflect a variable vul nerability to trauma of the endothelium and its basal production of prostacyclin in the different prepara tions used. In retrospect, it is now clear that either basal production of such endogenous metabolites must be measured throughout the experiment or their production must be inhibited and a known concentration of metabolite(s) substituted. The problem of endothelial integrity in vitro can no longer be ignored, and histological controls are nec- essary (Furchgott and Zawadzki, 1980 ; Lee , 198 1) . It should also be remembered that arachidonic acid itself can induce such endothelial cell damage (Kontos et aI ., 1980 ; Ingerman-Wojanski et aI ., 1981) . This endothelial phenomenon may explain the different results reported in canine cerebral ar teries. Toda and Miyazaki (1978) found that aspirin and indomethacin potentiated the contractile effects of PGF2" and PGE2 on helical strips, whereas Chapleau et al. (1980) found that aspirin had no ef fect and meclofenamate/indomethacin in high con centrations inhibited the contractile effect of PGF2" on ring segments. The ring segment technique may cause greater endothelial damage than helical strips. Toda and Miyazaki's results may reflect inhibition of endothelial prostacyclin synthetase. Arachidonic acid itself contracts isolated cerebral arteries but relaxes pial arterioles in vivo ; both ef fects are blocked by indomethacin. This suggests that in vitro arachidonic acid is converted predomi nantly by vascular smooth muscle to a vasocon strictor prostaglandin, whereas in vivo, transforma tion by endothelial cyclo-oxygenase and prosta cyclin synthetase predominates. In the mouse, there is a transient contraction fo llowed by dilata tion.
J Cereb Blood Flow Metabol. Vol. I. No. 4, 1981 PGH2 has a biphasic effect, with the delayed relax ation probably due to fo rmation of prostacyclin since it was blocked by inhibitors of prostacyclin synthetase (15-hydroperoxyarachidonic acid and tranylcypromine). Of great interest is the prolonged vasodilatation of pial arterioles provoked by PGG2 • PGF2" consistently contracts extracerebral arteries. PGE2 contracts cerebral arteries in vitro and in vivo but relaxes feline pial arterioles. PGD2 is a weak vasodilator of pial arterioles in vivo .
In almost all species, prostacyclin relaxes cere bral arteries and pial arterioles in doses below 10-6 M. At 10-5 M, it contracts isolated arteries. Uski et al . (1981) have been unable to induce relaxation in feline arteries in vitro with PGI2 , but there is no doubt about the potent pial vasodilatation it pro duces in vivo in the cat (Ellis et ai , 1979; Pickard et aI ., 198Od) . In the rat, prostacyclin-induced relaxa tion or contraction is dependent on the agent used to provide basal tone . Thromboxane A2 is the most potent vasoconstrictor of cerebral vessels known, whereas 6-keto-PGFj" has no significant effect on cerebral vessels.
The concept that arachidonate metabolites may modulate sympathetic neurotransmission (Hed qvist, 1970) has been extended to include other neurotransmitters and vasoactive peptides (e .g. , Mullane and Moncada, 1980) . When catecholamine neurotransmitters bind to the cell surface , they stimulate the methyltransferase enzymes. Such methylation of membrane phospholipids is coupled to calcium influx and the release of arachidonic acid, lysophosphatidylcholine , and prostaglandins (Hirata and Axelrod, 1980) . Conversion of this arachidonic acid to various metabolites might then modulate the primary effect of the amine on calcium influx and release. In isolated cerebral arteries fr om a variety of species, Hardebo et al . (198 1) did not find that indomethacin in specific doses has any ef fect on the contractions induced by noradrenaline , serotonin, histamine , and UTP nor on the relaxa tions induced by acetylcholine, histamine , isopren aline , ATP, or adenosine. Brandt (1981) found a moderate potentiation of the contractile effect of noradrenaline but not of serotonin by indomethacin on the isolated human pial artery .
The contractile effect of bradykinin on isolated canine cerebral arteries is attentuated by aspirin and indomethacin (Toda, 1977) . The vasodilator effect of vasoactive intestinal peptide on pial arterioles is completely inhibited by indomethacin, 3 mg/kg , administered intravenously (Wei et ai ., 198Oc) . The b Relaxation at less than 10-7 M; contraction at 10-6 M. ,. Relaxation up to 10-7 M; contraction at 10-5 M. d Late relaxation blocked by 15HPAA and tranylcypromine. e Transient contraction fo llowed by relaxation. f Relaxation or contraction depends on the agent stimulating basal tone . Abbreviations: AA, arachidonic acid; Ang., angiography; PG, prostaglandin; PGI2 , prostacyclin; TX, thromboxane ; C, contraction; R, relaxation; 0, no effect. effect of angiotensin II on pial arterioles in the cat displays remarkable tachyphylaxis (Acar and Pick ard , 1978) . In the kidney, Aiken and Vane (1973) demonstrated that such tachyphylaxis is caused by intrarenal prostaglandin release. In the dog, angio tensin II relaxes isolated cerebral arteries when contracted with PGF2o< (Toda and Miyazaki, 198 1). This angiotensin II-induced relaxation is blocked by both aspirin and indomethacin and by inhibitors of prostacyclin synthetase (15-hydroperoxyarachi donic acid and tranylcypromine). If this observation can be extended to other species, it may explain the paradox that angiotensin II is a very potent con strictor of pial arterioles but has little effect on CBF even after disruption of the blood-brain barrier (Pickard et aI. , 1977; Pickard , 1978, 1980; Wei et al. , 1978; Edvinsson et al. , 1979) .
In summary , these findings confirm that caution is necessary in extrapolating fr om in vitro to in vivo and from pial arteriolar responses to cerebral tissue perfusion. Prostacyclin is a potent cerebral vaso dilator and modulates the effects of some vasoac tive peptides on cerebrovascular smooth muscle.
Clinical Significance of Cerebral
Arachidonate Metabolism
How far can excessive production of throm boxane A2 , PGF2o< ' or PGE2 or defective synthesis of prostacyclin explain the cerebrovascular changes after various intracranial results? Are cyclo oxygenase or lipoxygenase products involved in the various types of oedema formation? How quantita tively important is intracerebral platelet deposition after subarachnoid haemorrhage , stroke, or head injury?
There is little difficulty in constructing hypoth eses, but the problems of measuring the concentra tions of the different cyclo-oxygenase and lipoxy genase products in the different compartments of the human brain are formidable (e.g. , Granstrom, 1980, for discussion) . There are interactions be tween the various arachidonic acid pathways so that inhibition of, say, thromboxane synthetase in creases the fo rmation of PGE2 and PGF2a in some tissue by shunting the endoperoxides to the stable prostaglandins (Harris et ai. , 1980; Moncada and Vane , 1980) . At this stage only fragmentary observations are available. Not surprisingly , marked increases in CSF PG levels are found with various intracranial afflictions, including epilepsy, head injuries, sub arachnoid haemorrhage , craniotomy, and menin gitis. Levels are very variable at different times even in the same patient. Changes in prostaglandin levels do not correlate well with the evolution of the pathological process (La Torre et ai. , 1974 ; Wolfe and Mamer, 1975; Carasso et ai. , 1977 ; Landau and Young, 1977 ; Hagen et ai. , 1977 ; Egg et ai. , 1978) .
Intracerebral platelet deposition has been demon strated in a number of experimental models such as around areas of vasogenic and ischaemic oedema (Costa et ai. , 1974; Segawa and Patterson, 198 1) , neural trauma (Goodman et ai. , 1979) and in areas of endothelial disruption at sites of cerebral arterial constriction (Symon, 1967) . There are considerable difficulties with attempts to quantify such platelet deposition in man (Agnoli and Fazio , 1977) whether by using labelled platelets or platelet markers such as ,B-thromboglobulin. Massive concentrations of lo cally applied prostacyclin (100 fLg/ml) will delay platelet aggregation induced in mouse pial venules by exposing them to a filtered mercury light source following intravenous sodium fluorescein (Rosen blum and El-Sabban, 1979) . Tranylcypromine in hibits prostacyclin synthetase in vitro and enhances platelet aggregation in mouse pial vessels but only marginally reduces the level of 6-keto-PGFla in vivo (Ellis et aI. , 198 1a) . In an important paper, Hallen beck and Furlow (1979) have shown that the rather drastic technique of compression ischaemia of the brain in dogs is fo llowed by areas of diminished perfusion. Pre-treatment of these animals with in domethacin or the combination of indomethacin and prostacyclin after ischaemia significantly enhances post-ischaemic re-perfusion. In contrast, where No. 4, 1981 intracerebral platelet deposition was reduced around a cold injury in the cerebral cortex, vaso genic oedema increased as the filling of the micro circulation improved (Segawa and Patterson, 198 1) .
Indomethacin has no effect on the development of vasogenic cerebral oedema in the cat (Pappius and Wolfe , 1976; Pickard , 198 1) . In an elegant series of studies in the gerbil, Iannotti et al. (1981) have shown that ischaemic cerebral oedema following carotid ligation increases with decreasing cerebral blood flow until, at no flow , there is no oedema fo rmation. Both indomethacin (cyclo-oxygenase in hibitor) and dexamethasone (phopholipase inhib itor) reduce oedema fo rmation in the low flow range , where membrane integrity is known to be impaired (Astrup et ai. , 1977) . Branston et al. (1981) did not find this effect in the baboon middle cerebral artery occlusion model, but there were differences in the method of solution of the indomethacin that need to be resolved. Of interest is the increase in brain water content with indomethacin alone at low doses in the gerbil (Iannotti et ai. , 198 1) and at high doses in the cat (Pickard , 198 1) . One possibility is that free arachidonic acid may be shunted down the lipoxygenase pathway in the presence of in domethacin (Higgs and Flower, 198 1) . Arachidonic acid induces a swelling of cerebral cortical slices that is independent of indomethacin (Chan and Fishman, 1978) .
Delayed cerebral ischaemia occurs naturally after subarachnoid haemorrhage but often appears to be aggravated by surgical intervention, particularly when this is performed during the first week after rupture of the aneurysm. Cerebral vasospasm is rarely seen prior to 3 days after the first bleed, is maximal around the end of the first week, and de clines thereafter (Wilkins , 1980, for review) . The capricious relationship between spasm and neurological deficit may reflect the ability of the individual's cerebral circulation to accommodate to such narrowed vessels: tissue ischaemia may be exacerbated when a fu rther stress is applied such as a period of hypotension (Pickard et ai. , 198Oc) .
Clotted blood releases many vasoactive sub stances, including serotonin, bradykinin, throm boxane A2 , adenine nucleotides, catecholamines, haemoglobin derivatives, and fibrin degradation products. All have been proposed as candidates for the provocation of cerebral vasospasm (Boullin , 1980; Wilkins, 1980, for review) . However, most of these compounds are released immediately, whereas vasospasm is not present initially but pro-gressively develops over the succeeding days. Contractions of cerebral arteries produced in vitro by many of the substances listed can be inhibited with appropriate blockers or synthesis inhibitors . In contrast, human cerebral vasospasm is refractory to such therapy.
Prolonged incubation of clotted blood, however, does result in the production of some ill-defined de rivatives of haemoglobin that in high concentrations are vasoconstrictor. Furthermore, there is now evi dence , fr om computed tomography scanning per formed within 48 h of the subarachnoid haemor rhage , that branches of the circle of Willis that are enveloped by thick clots are more likely to become narrowed than those arteries with little or no such clot. Clearly there is a relationship between periarterial haematoma and subsequent arterial nar rowing , but the relationship is not a simple one .
Cerebral vasospasm may be the end result of competition between the changing properties of the cerebral endothelium and vascular smooth muscle cell and the evolving pattern of sub stances to which they are exposed. It has been suggested that lipid peroxidation or free radical reactions , initiated either by hypertension, trauma, or clot lysis, damage the vascular endothelium and act as specific inhibitors of prostacyclin synthetase in the vessel wall (Sasaki et aI ., 1979; Kontos et aI ., 1980) . In an elegant series of studies, Kontos and co-workers have shown that acute hypertension, induced either by experimental brain injury or by the intravenous administration of vasoconstrictor agents, causes discrete destructive lesions in the endothelial lining of the cat's pial arterioles (Kontos et aI ., 1980 (Kontos et aI ., , 1981 Wei et al ., 198 0a, 1981) . After the hypertensive episode, these arterioles display sus tained vasodilatation and reduced responsiveness to changes in P aC02 and to changes in arterial blood pressure . All of these abnormalities are reduced by treatment with cyclo-oxygenase inhibitors and by topical application of fr ee radical scavengers to the brain surface . Topical application of arachidonic acid and PGG2 to the brain surface induces similar cerebral arteriolar damage that is inhibited by scavengers of free oxygen radicals. Kontos suggests that the mechanism of the arteriolar abnormalities fro m acute hypertension involves a sudden increase in prostaglandin synthesis that leads to generation of free oxygen radicals (Ellis et al ., 1981b) . Hughes and Schianchi (1978) have reported pathological changes in the endothelium of cerebral arteries known to have been in spasm in life. Such vascular damage leads to platelet adhesion and, if sufficiently severe , to thrombus formation. Pros tacyclin is responsible for much if not all of the thromboresistant properties of vascular en dothelium Vane , 1978, 1979) . Platelet aggregation generates thromboxane A2 release, which leads to further cerebral arterial contraction and endothelial disruption. With experimental ath erosclerosis, the fall in prostacyclin production oc curs before any detectable anatomical damage (Dembinska-Kiec et aI ., 1977) . Boullin (1980) has popularized the concept that part of the sequence of events precipitating cerebral vasospasm may be prostacyclin deficiency . This concept is particularly relevant in view of the benefit afforded some pa tients with lower limb arterial occlusive disease by a 3-day infusion of prostacyclin (Vane , 1980) . The only evidence for such prostacyclin deficiency is the impaired prostacyclin synthetase activity of canine basilar arteries after subarachnoid haemor rhage (Sasaki et aI., 1981) . The intracarotid infusion of a thromboxane A2 generating system (thrombin and a suspension of platelets) reduces CBF and pre cipitates a stroke-like syndrome in the majority of rabbits (Shimamoto, 1977; Asano et aI ., 1978) . There is a danger when discussing coupling mechanisms to allow experimental pathology to overshadow normal physiology: indomethacin probably interfe res with the latter only. The normal extracellular ionic response to neuronal activity is a rise in K+ and a fall in H+ and Ca 2 + (Nicolson et aI ., 1977; Cameron, 1977; Purves, 1978) . Like other vascular smooth muscle , isolated cerebral arteries and pial arterioles contract when the extracellular potassium concentration is reduced from 10 to 0 mM (Kuschinsky et aI ., 1972; Toda, 1974 Toda, , 1976 Betz et aI ., 1975; Pickard et aI ., 1975b Pickard et aI ., , 1976 Cameron and Caronna, 1976) . This behaviour is attributed to the operation of an electrogenic sodium pump that is inhibited at 0 mM K+ and near maximally active at 10 mM K. Siegel et ai . (1976) have recorded a small depolarization of middle cerebral arterial muscle cells when they are transferred from 2.5 to 0 mM K. At the normal CSF potassium concentration of 3 mM, the sodium pump may not be maximally active . Consistent with this view is the finding that the sodium concentration of canine cerebral arteries is significantly greater than those of systemic arteries (Toda, 1976) . If cerebral arteries are pre-incubated in 0 mM K at 37°C, transfer to the normally contrac tile potassium concentration of 25 mM produces a relaxation for some minutes, followed by a contrac tion (Pickard , 198 1) . If ouabain is added after in cubation at 0 mM K, transfer to 25 mM K produces an immediate contraction. This phenomenon has been used as an indicator of Na+-K+ ATPase activ ity in extracranial vascular smooth muscle (Webb and Bohr, 1978) . It explains the high concentration of potassium required to produce pial and paren chymal arteriolar constriction in vivo (Kuschinsky et aI ., 1972; Betz et aI ., 1975 ; Cameron and Caronna, 1976) ; a large depolarization is required to over come the hyperpolarizing effect of fully activating the electrogenic sodium pump. A fall in extracellu lar fluid (ECF) pH is well documented as a cerebral vasodilator, and the effects of carbon dioxide have been attributed completely to the change in ECF pH (Cameron , 1977, for review) . Although CO2 and ECF pH have similar effects on Aplysia neurones (Walker and Brown, 1970) , they have very different effects not only in the bovine middle cerebral artery (Pickard et aI ., 1975b (Pickard et aI ., , 1976 Pickard , 1981) , but also in myocardium (Poole-Wilson and Langer, 1975) , Taenia coli (Weinbeck et aI ., 1972) , and various vascular beds (e.g., Kontos et aI ., 1968) . Kontos et aI . (1977) found that CO2 and ECF pH had similar effects on pial arterioles in the cat. These findings are not inconsistent with findings in the middle ce rebral artery . At the normal CSF potassium of 3 mM, increasing the CO2 concentration at constant bicarbonate concentration provoked a transient contraction followed by a small vasodilatation (Pick ard et aI ., 1976; Pickard , 198 1) . In the pial window technique, the exact perivascular and transmural concentrations of agents are much more difficult to control precisely than in vitro , and it would be dif ficult to detect the small differences between pro longed ECF pH and CO2 effects in vivo . As the potassium concentration is changed, the differences between CO2 and ECF pH become more obvious. These differential effects may reflect the difference between simple acidic inhibition of Ca 2 + influx by changes in ECF pH (Weiss, 1966 ; Morganstern et aI ., 1972; Landau and Nachsen, 1975 ; Pickard et aI ., 1976) and the effect on intracellular binding of Ca 2 + by changes in intracellular pH produced initially by CO2 (Pickard, 1976) . The latter phenomenon has been described in other tissues, but the situation is complex (Fabiato and Fabiato, 1978 Ashley, 1978). Of course , pH has many other ef fects on the vascular smooth muscle cell, including changes in chloride conductance (MacLellan et aI ., Pickard and Spurway, 1974) , and our understand ing of the overall effects of pH on smooth muscle remains rudimentary (Brading, 1979) . The cellular effects of prostaglandins remain curiously ill-defined (Bolton , 1979; Harris et aI ., 1979 , for reviews) and revolve around cyclic AMP, cyclic GMP, and control of calcium influx and its intracellular sequestration. One tantalizing recent observation is the finding that some prostaglandins potentiate sodium-pump activity (Lockette et aI ., 1980) . Toda (1974) fo und that the size of the potassium-induced relaxation in canine cerebral arteries increased when base-line tone was in creased with PGF2a • Inhibition of the sodium pump in Taenia coli is associated with the release of PGE2 and 6-keto-PGF 1 a (Coburn et aI ., 1980) . The in teractions of CO2 and ECF pH with the sodium pump in vascular smooth muscle have not yet been defined.
In the bovine middle cerebral artery in vitro, in domethacin has no effect on changes in contraction produced by ECF pH-only on changes produced by CO2-but the mechanism of these changes is not clear (Pickard et aI ., 1976) .
Conclusions
Carbon dioxide and the cerebral extracellular/ CSF potassium concentration of 3 mM set a basic cerebrovascular tone . The CO2 component is se verely impaired by indomethacin, an action that is reversed by prostacyclin. Prostacyclin is synthe sized in the cerebrovascular endothelium. Cere brovascular smooth muscle and/or brain tissue may generate PGF2a , PGD2, PGE2, and thromboxane A2 which may modulate the activity of the vascular smooth muscle cell. Prostacyclin modulates the effects of some vasoactive peptides such as an giotensin II, vasoactive intestinal peptide, and bradykinin but probably not neurotransmitter amines such as noradrenaline , serotonin, histamine , or acetylcholine . Indomethacin probably has no ef fe ct on the cerebral hyperaemia induced by hypox ia, hypoglycaemia, or seizures. Heinemann, pp 78-95 Toda N (1974) 
